Iterum Therapeutics plc

Ownership Transactions Reported by 10 Insiders

Symbol
ITRM on Nasdaq
Location
3 Dublin Landings, North Wall Quay, Dublin 1, Ireland

There are no Buy or Sell transactions made by insiders since 4/20/2024

Iterum Therapeutics plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ronald Hunt Director $483K Jan 13, 2025
Michael W. Dunne Director $308K Aug 6, 2024
Corey N. Fishman Chief Executive Officer, Director $192K Aug 6, 2024
Judith M. Matthews Chief Financial Officer $92.4K Mar 31, 2023
Sailaja Puttagunta Chief Medical Officer $75.3K Dec 1, 2023
David G. Kelly Director $52.4K Jun 15, 2022
Beth Hecht Director $26.4K Jun 15, 2023
Mark Chin Director $25.6K Jun 15, 2023
Brenton K. Ahrens Director $24.2K Dec 23, 2022
Joseph J. Whalen Director Mar 10, 2025

Recent Insider Transactions by Companies or Individuals for Iterum Therapeutics plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.